By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Selecta Biosciences, Inc. 

480 Arsenal Street
Building One
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-923-1400 Fax: 617-924-3454


Company News
Selecta (SELB) Announces Second Quarter 2017 Financial Results And Provides Corporate Update 8/11/2017 10:47:57 AM
Selecta (SELB) To Report Second Quarter 2017 Financial Results On Friday, August 11, 2017 8/4/2017 11:10:20 AM
Massachusetts' Selecta (SELB) Banks $50 Million 6/26/2017 9:52:49 AM
Selecta (SELB) Announces Addition Of Patrick J. Zenner To Board Of Directors 6/19/2017 8:40:10 AM
Selecta (SELB) Reports Data From Ongoing Phase II Trial Of Lead Candidate, SEL-212, In Development For Chronic Severe Gout 6/15/2017 8:19:50 AM
Lyophilization Services of New England Contract Manufacturing Announces Manufacturing Agreement With Selecta (SELB) 5/24/2017 8:14:23 AM
Selecta (SELB) Announces First Quarter 2017 Financial Results And Provides Corporate Update 5/12/2017 12:32:34 PM
Selecta (SELB) Commences Dosing In Phase I Clinical Trial Of Nicotine Vaccine For Smoking Cessation And Relapse Prevention 5/12/2017 11:27:51 AM
Selecta (SELB) To Report First Quarter 2017 Financial Results On Thursday, May 11, 2017 5/4/2017 10:45:16 AM
Selecta (SELB) Obtains License For Recombinant Immunotoxin LMB-100 From NCI) For Pancreatic Cancer, Mesothelioma And Other Cancers 5/2/2017 10:13:18 AM